Livio Luongo
Livio Luongo is an expert in Pharmacy at Azienda Ospedaliera Universitaria Università degli Studi della Campania Luigi Vanvitelli (Italy). As of October 2026, ScienceLeadR ranks Livio Luongo in the top 1% of experts worldwide for Pain. Livio Luongo has authored 208 publications, the most recent in 2026. SLR score: 537 (community average: 125). How the SLR is computed.
LeadR Profile
Pharmacy
Subspecialties: Neurology - Endocrinology - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2008 - 2026
Number : 208
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Adolescent social isolation drives sex-dependent shifts in medial prefrontal cortex endocannabinoid tone and excitatory/inhibitory balance: the protective role of a methyl donor. PMID 42933530 — depression, pain, hypersensitivity, social isolation, glycine, adolescent, prefrontal cortex, sex, endocannabinoids, therapeutics | Neuropharmacology | 2026 | 0 |
| Design, synthesis and structural mechanism of action of TRPV1 agonist MSP20 with long-lasting analgesic effect. PMID 42409805 — biological science disciplines, analgesics | Nat Commun | 2026 | 0 |
| Early life social isolation stress and pain vulnerability: unraveling neuroimmune mechanisms and central sensitization. PMID 42305441 — cells, neurons, central nervous system sensitization, pain, social isolation, stress, physiological, neuroimmunomodulation, neuroglia, research, therapeutics, spine, nociplastic pain | Front Pharmacol | 2026 | 1 |
| Anesthesia and medical cannabis: an integrated approach. PMID 42187203 — dronabinol, anesthesia, anesthesiology, pain, anesthetics, anesthesiologists, cannabinoids, medical marijuana | Minerva Anestesiol | 2026 | 0 |
| Differential Target Multiplexed Spinal Cord Stimulation in Persistent Spinal Pain Syndrome Type II: A Multicenter Prospective Study. PMID 42159521 — cytokines, quality of life, safety, spinal cord, pain, spinal cord stimulation, biomarkers, therapeutics, prospective studies, spine | Neuromodulation | 2026 | 0 |
LeadR Networks
Main global connection map